Global Intravenous Fluid Bags Market 2024-2028

Description

List of Tables

The intravenous fluid bags market is forecasted to grow by USD 846.08 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the intravenous fluid bags market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, aging population worldwide, and increase in healthcare expenditure by government and constitutional bodies globally.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.37%
CAGR	6.01%
Incremental Value	$846.08mn

Technavio's intravenous fluid bags market is segmented as below:

By Type

PVC material
Non-PVC material

By End-user

Hospitals
Home healthcare
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the innovations and advancements in material technology as one of the prime reasons driving the intravenous fluid bags market growth during the next few years. Also, rising focus on single-use and sterility and increasing adoption of home healthcare and ambulatory settings will lead to sizable demand in the market.

The report on the intravenous fluid bags market covers the following areas:

Intravenous fluid bags market sizing
Intravenous fluid bags market forecast
Intravenous fluid bags market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous fluid bags market vendors that include Alfa Laboratories SAL, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., DL Chemical, Fosmo Med, Fresenius SE and Co. KGaA, ICU Medical Inc., Macopharma, Medicopack, Otsuka Holdings Co. Ltd., Pharmaceutical Solutions Industry, Polifarma Ilac San ve Tic AS, PolyCine GmbH, RENOLIT SE, Sartorius AG, SIPPEX, Technoflex, The Metrix Co., Vioser SA, Wellpharma, and West Pharmaceutical Services Inc.. Also, the intravenous fluid bags market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40565

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global intravenous fluid bags market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global intravenous fluid bags market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 PVC material - Market size and forecast 2023-2028
Exhibit 34: Chart on PVC material - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on PVC material - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on PVC material - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on PVC material - Year-over-year growth 2023-2028 (%)
6.4 Non-PVC material - Market size and forecast 2023-2028
Exhibit 38: Chart on Non-PVC material - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Non-PVC material - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Non-PVC material - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Non-PVC material - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Home healthcare - Market size and forecast 2023-2028
Exhibit 52: Chart on Home healthcare - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Home healthcare - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Home healthcare - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Home healthcare - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Alfa Laboratories SAL
Exhibit 111: Alfa Laboratories SAL - Overview
Exhibit 112: Alfa Laboratories SAL - Product / Service
Exhibit 113: Alfa Laboratories SAL - Key offerings
12.4 B.Braun SE
Exhibit 114: B.Braun SE - Overview
Exhibit 115: B.Braun SE - Business segments
Exhibit 116: B.Braun SE - Key news
Exhibit 117: B.Braun SE - Key offerings
Exhibit 118: B.Braun SE - Segment focus
12.5 Baxter International Inc.
Exhibit 119: Baxter International Inc. - Overview
Exhibit 120: Baxter International Inc. - Business segments
Exhibit 121: Baxter International Inc. - Key news
Exhibit 122: Baxter International Inc. - Key offerings
Exhibit 123: Baxter International Inc. - Segment focus
12.6 DL Chemical
Exhibit 124: DL Chemical - Overview
Exhibit 125: DL Chemical - Product / Service
Exhibit 126: DL Chemical - Key offerings
12.7 Fosmo Med
Exhibit 127: Fosmo Med - Overview
Exhibit 128: Fosmo Med - Product / Service
Exhibit 129: Fosmo Med - Key offerings
12.8 Fresenius SE and Co. KGaA
Exhibit 130: Fresenius SE and Co. KGaA - Overview
Exhibit 131: Fresenius SE and Co. KGaA - Business segments
Exhibit 132: Fresenius SE and Co. KGaA - Key news
Exhibit 133: Fresenius SE and Co. KGaA - Key offerings
Exhibit 134: Fresenius SE and Co. KGaA - Segment focus
12.9 ICU Medical Inc.
Exhibit 135: ICU Medical Inc. - Overview
Exhibit 136: ICU Medical Inc. - Product / Service
Exhibit 137: ICU Medical Inc. - Key offerings
12.10 Otsuka Holdings Co. Ltd.
Exhibit 138: Otsuka Holdings Co. Ltd. - Overview
Exhibit 139: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 140: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 141: Otsuka Holdings Co. Ltd. - Segment focus
12.11 Pharmaceutical Solutions Industry
Exhibit 142: Pharmaceutical Solutions Industry - Overview
Exhibit 143: Pharmaceutical Solutions Industry - Product / Service
Exhibit 144: Pharmaceutical Solutions Industry - Key offerings
12.12 RENOLIT SE
Exhibit 145: RENOLIT SE - Overview
Exhibit 146: RENOLIT SE - Product / Service
Exhibit 147: RENOLIT SE - Key offerings
12.13 SIPPEX
Exhibit 148: SIPPEX - Overview
Exhibit 149: SIPPEX - Product / Service
Exhibit 150: SIPPEX - Key offerings
12.14 Technoflex
Exhibit 151: Technoflex - Overview
Exhibit 152: Technoflex - Product / Service
Exhibit 153: Technoflex - Key offerings
12.15 The Metrix Co.
Exhibit 154: The Metrix Co. - Overview
Exhibit 155: The Metrix Co. - Product / Service
Exhibit 156: The Metrix Co. - Key offerings
12.16 Vioser SA
Exhibit 157: Vioser SA - Overview
Exhibit 158: Vioser SA - Product / Service
Exhibit 159: Vioser SA - Key offerings
12.17 Wellpharma
Exhibit 160: Wellpharma - Overview
Exhibit 161: Wellpharma - Product / Service
Exhibit 162: Wellpharma - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 163: Inclusions checklist
Exhibit 164: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 165: Currency conversion rates for US$
13.4 Research methodology
Exhibit 166: Research methodology
Exhibit 167: Validation techniques employed for market sizing
Exhibit 168: Information sources
13.5 List of abbreviations
Exhibit 169: List of abbreviations